Skip to main content
Equibles
IMVT logo

IMVT · Immunovant, Inc. · Earnings Call Transcripts & Audio

Track IMVT — free

Use IMVT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMVT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$33.78 +0.32 (+0.96%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$6.88B
Shares
206.55M
Volume · Sep 30 1.43M Avg daily vol (3M) 1.22M

Immunovant, Inc. Earnings Call Transcripts

Quarterly earnings calls for Immunovant, Inc. (IMVT), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY27 · Q1
2026-08-06
Immunovant, Inc. (IMVT) Q1 2027 Earnings Call
Diluted EPS
$-0.75
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-05-20
Immunovant, Inc. (IMVT) Q4 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-02-06
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Confident tone Thyroid Eye Disease (TED) BREPO Phase 2 in Cutaneous Sarcoidosis Graves' Disease / Competitive Landscape
Diluted EPS
$-0.61
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-10
Immunovant, Inc. (IMVT) Q2 2026 Earnings Call Transcript
Confident tone Competitive landscape in TED and myositis Batoclimab and IMVT-1402 in Graves' disease Brepocitinib VALOR Phase 3 data in dermatomyositis
Diluted EPS
$-0.73
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-07
Immunovant, Inc. (IMVT) Q2 2025 Earnings Call Transcript
Confident tone Competitive landscape in Graves' and TED Batoclimab and IMVT-1402 in Graves' disease Catalyst roadmap and upcoming readouts
Diluted EPS
$-0.74
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-05
Immunovant, Inc. (IMVT) Q1 2023 Earnings Call
Diluted EPS
$-0.35
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-06-08
Immunovant, Inc. (IMVT) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q1
2021-08-09
Immunovant, Inc. (IMVT) Q1 2022 Earnings Call Transcript
Diluted EPS
$-0.31
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-01
Immunovant, Inc. (IMVT) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–9 of 9 earnings calls
Key facts CIK 1764013 CUSIP 45258J102 13F (30d) 7 filings 7 filers Visit website Investor relations